Moderna Asks Fed. Circ. To Undo Drug-Delivery Patent Ruling
Moderna urged the Federal Circuit to reverse the Patent Trial and Appeal Board's decision to uphold an Arbutus patent for a drug-delivery composition, saying that the board "improperly applied an anticipation...To view the full article, register now.
Already a subscriber? Click here to view full article